Etropal AD (XBUL:ETR) Asset Turnover: 1.07 (As of Dec. 2025)

What is Etropal AD Asset Turnover?

Etropal AD XBUL:ETR 50 Asset Turnover is 1.07 as of Dec. 2025. GuruFocus rates XBUL:ETR with a GF Score™ of 50/100 and a GF Value™ of €8.59 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Etropal AD's Revenue for the six months ended in Dec. 2025 was €10.39 Mil. Etropal AD's Total Assets for the quarter that ended in Dec. 2025 was €9.73 Mil. Therefore, Etropal AD's Asset Turnover for the quarter that ended in Dec. 2025 was 1.07.

Asset Turnover is linked to ROE % through Du Pont Formula. Etropal AD's annualized ROE % for the quarter that ended in Dec. 2025 was 7.15%. It is also linked to ROA % through Du Pont Formula. Etropal AD's annualized ROA % for the quarter that ended in Dec. 2025 was 3.21%.

Etropal AD (XBUL:ETR) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Etropal AD's annulized ROE % for the quarter that ended in Dec. 2025 is

	ROE %^**		(Q: Dec. 2025 )
=	Net Income	/	Total Stockholders Equity
=	0.312	/	4.3655
=	(Net Income / Revenue)	*	(Revenue / Total Assets)	*	(Total Assets / Total Stockholders Equity)
=	(0.312 / 20.78)	*	(20.78 / 9.7295)	*	(9.7295/ 4.3655)
=	Net Margin %	*	Asset Turnover	*	Equity Multiplier
=	1.5 %	*	2.1358	*	2.2287
=	ROA %	*	Equity Multiplier
=	3.21 %	*	2.2287
=	7.15 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

^** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Etropal AD's annulized ROA % for the quarter that ended in Dec. 2025 is

	ROA %		(Q: Dec. 2025 )
=	Net Income	/	Total Assets
=	0.312	/	9.7295
=	(Net Income / Revenue)	*	(Revenue / Total Assets)
=	(0.312 / 20.78)	*	(20.78 / 9.7295)
=	Net Margin %	*	Asset Turnover
=	1.5 %	*	2.1358
=	3.21 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.

Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.

Etropal AD Asset Turnover Related Terms

Etropal AD Asset Turnover Historical Data

* Premium members only.

The historical data trend for Etropal AD's Asset Turnover can be seen below:

Etropal AD Asset Turnover Chart

Etropal AD Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Asset Turnover

Get a 7-Day Free Trial

0.77

0.39

0.61

0.86

1.07

Etropal AD Semi-Annual Data
	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec20	Dec21	Dec22	Dec23	Dec24	Dec25
Asset Turnover	Get a 7-Day Free Trial										0.77	0.39	0.61	0.86	1.07

XBUL:ETR vs ISRG, BDX, MDLN: Asset Turnover Comparison

For the Medical Instruments & Supplies subindustry, Etropal AD's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Etropal AD Asset Turnover vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Etropal AD's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Etropal AD's Asset Turnover falls into.

Save Embed

50GF Score

Etropal AD XBUL:ETR

Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Etropal AD Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Etropal AD's Asset Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Asset Turnover
=	Revenue	/	Average Total Assets
=	Revenue (A: Dec. 2025 )	/	( (Total Assets (A: Dec. 2024 )	+	Total Assets (A: Dec. 2025 ))	/ count )
=	10.39	/	( (9.45	+	10.009)	/ 2 )
=	10.39	/	9.7295
=	1.07

Etropal AD's Asset Turnover for the quarter that ended in Dec. 2025 is calculated as

	Asset Turnover
=	Revenue	/	Average Total Assets
=	Revenue (Q: Dec. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Dec. 2025 ))	/ count )
=	10.39	/	( (9.45	+	10.009)	/ 2 )
=	10.39	/	9.7295
=	1.07

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →

What does a Asset Turnover of 1.07 mean?

Etropal AD (XBUL:ETR) has a Asset Turnover of 1.07 as of Dec. 2025. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Etropal AD and its competitors.

Is Etropal AD's Asset Turnover too high?

Etropal AD's current Asset Turnover is 1.07. Overall, Etropal AD has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Etropal AD's Asset Turnover compare to ISRG and BDX?

Etropal AD's Asset Turnover of 1.07 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Asset Turnover for a Medical Devices & Instruments company?

A good Asset Turnover depends on the Medical Devices & Instruments industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Asset Turnover mean?

A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Etropal AD and its competitors. Etropal AD's current Asset Turnover is 1.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Etropal AD stock overvalued right now?

Based on GuruFocus' analysis, Etropal AD (XBUL:ETR) is currently considered Significantly Undervalued. The stock's GF Value™ is €8.59, compared to a current price of €2.52 — trading 70.7% below its estimated fair value. The current Asset Turnover is 1.07. Etropal AD's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Asset Turnover calculated?

Asset Turnover is calculated from a company's financial statements. For Etropal AD (XBUL:ETR), the current Asset Turnover is 1.07 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Etropal AD (XBUL:ETR) Overvalued in 2026?

Based on GuruFocus' analysis, Etropal AD stock appears to be undervalued. The current stock price of €2.52 is trading 70.7% below its estimated GF Value™ of €8.59. GuruFocus considers Etropal AD to be Significantly Undervalued.

Key valuation signals for XBUL:ETR:

Asset Turnover: 1.07
GF Value™: €8.59 vs. price of €2.52 (70.7% below fair value)
GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the XBUL:ETR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Etropal AD Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies XBUL:MKR ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST XSWX:STMN TSE:4543 XPAR:DIM COO SOLV OCSE:COLO B NZSE:FPH ALGN BAX NSE:LENSKART RGEN

Address 191 Rusky Boulevard, Etropole, Sofia, BGR, 2180

Website http://www.etropal.eu

Etropal AD is engaged in the business of manufacturing medical accessories. The product portfolio includes fistula needles, blood taking sets, transfusion and infusion sets, catheters and tubes, urine collecting bags, colostomy bags, among others. The company also produces hip - joint endoprosthesis and instruments of implantation.

50GF Score

Get the complete analysis for XBUL:ETR

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.52

Price

€8.59

GF Value

View XBUL:ETR Analysis

See Asset Turnover data for all stocks →